Grown Rogue International Inc. Stock OTC Markets
Stocks
GRUSF
CA39986R3045
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.3924 USD | +0.61% |
|
-4.87% | -23.94% |
| 05-13 | Grown Rogue International Inc., Q1 2026 Earnings Call, May 12, 2026 | |
| 05-13 | Grown Rogue International Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| Market Cap | 92.1M 80.82M 75.27M 69.23M 130M 8.8B 132M 893M 350M 4.36B 346M 338M 15.08B | P/E 2024 |
-12x | P/E 2025 | 71.9x |
|---|---|---|---|---|---|
| Enterprise Value | 107M 94.25M 87.77M 80.73M 151M 10.26B 154M 1.04B 408M 5.09B 403M 394M 17.58B | EV / Sales 2024 |
5.45x | EV / Sales 2025 | 4.4x |
| Free-Float |
61.83% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Grown Rogue International Inc.
| 1 day | +0.61% | ||
| 1 week | -4.87% | ||
| Current month | -14.42% | ||
| 1 month | -3.33% | ||
| 3 months | +8.46% | ||
| 6 months | +6.05% | ||
| Current year | -23.94% |
| 1 week | 0.36 |  | 0.43 |
| 1 month | 0.36 | | 0.49 |
| Current year | 0.27 | | 0.52 |
| 1 year | 0.27 | | 0.52 |
| 3 years | 0.17 | | 0.9 |
| 5 years | 0.02 | | 0.9 |
| 10 years | 0 | | 0.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
J. Strickler
CEO | Chief Executive Officer | 45 | 15/11/2018 |
Sarah Strickler
PRN | Corporate Officer/Principal | - | 01/10/2016 |
| Director of Finance/CFO | 42 | 01/01/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Stephen Gledhill
BRD | Director/Board Member | 64 | 15/11/2018 |
J. Strickler
BRD | Director/Board Member | 45 | 15/11/2018 |
Ryan Kee
BRD | Director/Board Member | 42 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.61% | -4.87% | - | - | 92.1M | |
| +0.61% | -1.17% | -9.02% | -4.23% | 13.47B | |
| +0.24% | -3.30% | -29.72% | -50.27% | 5.15B | |
| +0.39% | +2.65% | +2.00% | +2.56% | 4.88B | |
| -0.84% | -5.68% | +3.36% | -32.08% | 4.13B | |
| -1.49% | -6.25% | +0.89% | -8.44% | 3.68B | |
| -1.86% | -1.31% | -2.83% | -2.94% | 3.67B | |
| -1.19% | -2.05% | -2.84% | +10.31% | 3.51B | |
| -1.82% | -1.33% | -13.46% | -23.88% | 2.48B | |
| +0.63% | -1.45% | -2.81% | +43.03% | 1.86B | |
| Average | -0.47% | -1.78% | -6.05% | -7.33% | 4.76B | |
| Weighted average by Cap. | -0.28% | -1.53% | -7.16% | -9.82% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 27.02M 23.71M 22.08M 20.31M 38.07M 2.58B 38.72M 262M 103M 1.28B 101M 99.24M 4.42B | 32.43M 28.46M 26.5M 24.37M 45.69M 3.1B 46.48M 314M 123M 1.54B 122M 119M 5.31B |
| Net income | -11.3M -9.92M -9.24M -8.5M -15.93M -1.08B -16.2M -110M -42.9M -536M -42.44M -41.52M -1.85B | 1.73M 1.52M 1.41M 1.3M 2.44M 165M 2.48M 16.77M 6.56M 81.96M 6.49M 6.35M 283M |
| Net Debt | 3.7M 3.25M 3.03M 2.78M 5.22M 354M 5.31M 35.91M 14.06M 176M 13.91M 13.61M 606M | 15.3M 13.43M 12.5M 11.5M 21.56M 1.46B 21.93M 148M 58.06M 725M 57.44M 56.2M 2.5B |
Employees
-
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/07/26 | $0.3924 | +0.61% | 129,578 |
| 27/07/26 | $0.3900 | -1.86% | 76,500 |
| 24/07/26 | $0.3974 | +0.61% | 71,599 |
| 23/07/26 | $0.3950 | -7.02% | 659,725 |
| 22/07/26 | $0.4248 | +2.99% | 110,508 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- GRIN Stock
- GRUSF Stock
Select your edition
All financial news and data tailored to specific country editions
